APOE -: 491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease

被引:33
|
作者
Casadei, VM
Ferri, C
Veglia, F
Gavazzi, A
Salani, G
Cattaneo, M
Sorbi, S
Annoni, G
Licastro, F
Mariani, C
Franceschi, M
Grimaldi, LME
机构
[1] Ist Sci San Raffaele, Clin Santa Maria Castellanza, Neuroimmunol Unit, Dept Neurosci, I-20132 Milan, Italy
[2] Ist Sci San Raffaele, Clin Santa Maria Castellanza, Neuroimmunol Unit, Biostat Unit, I-20132 Milan, Italy
[3] Ist Sci San Raffaele, Clin Santa Maria Castellanza, Dept Neurol, I-20132 Milan, Italy
[4] CNR, Ist Tecnol Biomed Avanzate, I-20131 Milan, Italy
[5] Univ Florence, Dept Neurol & Psychiat Sci, I-50121 Florence, Italy
[6] Univ Milan, Dept Geriatr, I-20122 Milan, Italy
[7] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy
[8] IRCCS Santa Maria Nascente, Neurorehabil Unit, Milan, Italy
[9] IRCCS Oasi Maria Santissima, Troina, Italy
关键词
APOE; AD; polymorphisms;
D O I
10.1212/WNL.53.8.1888
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1888 / 1889
页数:2
相关论文
共 50 条
  • [31] Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam study
    Roks, G
    Cruts, M
    Houwing-Duistermaat, JJ
    Dermaut, B
    Serneels, S
    Havekes, LM
    Hofman, A
    Breteler, MMB
    Van Broeckhoven, C
    van Duijn, CM
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 114 (05): : 570 - 573
  • [32] The genetics of late-onset Alzheimer's disease
    Myers, AJ
    Goate, AM
    [J]. CURRENT OPINION IN NEUROLOGY, 2001, 14 (04) : 433 - 440
  • [33] Cannabinoids in Late-Onset Alzheimer's Disease
    Ahmed, A. I. A.
    van der Marck, M. A.
    van den Elsen, G. A. H.
    Rikkert, M. G. M. Olde
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 (06) : 597 - 606
  • [34] The APOE-491 A/T promoter polymorphism effect on cognitive profile of Alzheimer's patients
    Valenza, A.
    Bizzarro, A.
    Marra, C.
    Lauria, A.
    Guglielmi, V.
    Rossi, C.
    Tiziano, F. D.
    Brahe, C.
    Masullo, C.
    [J]. NEUROSCIENCE LETTERS, 2010, 472 (03) : 199 - 203
  • [35] Increased risk of familial late-onset Alzheimer's disease in women
    Payami, H
    Montee, K
    Grimslid, H
    Shattuc, S
    Kaye, J
    [J]. NEUROLOGY, 1996, 46 (01) : 126 - 129
  • [36] The Impact of Complement Genes on the Risk of Late-Onset Alzheimer's Disease
    Carpanini, Sarah M.
    Harwood, Janet C.
    Baker, Emily
    Torvell, Megan
    Sims, Rebecca
    Williams, Julie
    Morgan, B. Paul
    [J]. GENES, 2021, 12 (03)
  • [37] Vascular risk and genetics of sporadic late-onset Alzheimer's disease
    Panza, F
    D'Introno, A
    Colacicco, AM
    Basile, AM
    Capurso, C
    Kehoe, PG
    Capurso, A
    Solfrizzi, V
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2004, 111 (01) : 69 - 89
  • [38] Risk Factors of late-onset Alzheimer's disease in the VITA study
    Peter, Fischer
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2008, 115 (10) : 1466 - 1466
  • [39] Vascular risk and genetics of sporadic late-onset Alzheimer’s disease
    F. Panza
    A. D’Introno
    A. M. Colacicco
    A. M. Basile
    C. Capurso
    P. G. Kehoe
    A. Capurso
    V. Solfrizzi
    [J]. Journal of Neural Transmission, 2004, 111 : 69 - 89
  • [40] Gene mutation increases risk of late-onset Alzheimer's disease
    不详
    [J]. PERSONALIZED MEDICINE, 2007, 4 (01) : 7 - 7